Re: Imatinib mesylate administration in the first 100 days after stem cell transplantation

Biol Blood Marrow Transplant. 2004 Dec;10(12):883-4. doi: 10.1016/j.bbmt.2004.09.004.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Benzamides
  • Graft Rejection / prevention & control
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
  • Middle Aged
  • Piperazines / therapeutic use*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
  • Protein Kinase Inhibitors / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Recurrence
  • Stem Cell Transplantation*
  • Time Factors
  • Treatment Outcome

Substances

  • Benzamides
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Imatinib Mesylate